Berhan A, Almaw A, Damtie S, Solomon Y
Discov Oncol. 2025; 16(1):184.
PMID: 39954204
PMC: 11829893.
DOI: 10.1007/s12672-025-01958-w.
Weniger M, Seifert M, Kuppers R
Methods Mol Biol. 2024; 2865:1-30.
PMID: 39424718
DOI: 10.1007/978-1-0716-4188-0_1.
Schapfl M, LoMastro G, Braun V, Hirai M, Levine M, Kiermaier E
Nat Commun. 2024; 15(1):8890.
PMID: 39406735
PMC: 11480410.
DOI: 10.1038/s41467-024-53222-4.
Klasener K, Herrmann N, Haversen L, Sundell T, Sundqvist M, Lundqvist C
Clin Transl Immunology. 2024; 13(10):e70011.
PMID: 39364393
PMC: 11447455.
DOI: 10.1002/cti2.70011.
Zhang J, Zhou S, Jiang S, He F, Tu Y, Hu H
J Cancer Res Clin Oncol. 2024; 150(9):426.
PMID: 39299959
PMC: 11413099.
DOI: 10.1007/s00432-024-05939-4.
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACE.
Camus V, Viennot M, Viailly P, Drieux F, Veresezan E, Bobee V
Blood Adv. 2024; 9(1):101-115.
PMID: 39293080
PMC: 11742575.
DOI: 10.1182/bloodadvances.2024013723.
Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen.
Kasprzyk M, Sura W, Podralska M, Kazimierska M, Seitz A, Losiewski W
Haematologica. 2024; 109(12):4007-4020.
PMID: 38934080
PMC: 11609794.
DOI: 10.3324/haematol.2023.284672.
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).
Hilton L, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng A
Blood. 2024; 144(5):525-540.
PMID: 38701426
PMC: 11307266.
DOI: 10.1182/blood.2024024251.
Mechanism and regulation of secondary immunoglobulin diversification.
Bello A, Hirth G, Voigt S, Tepper S, Jungnickel B
Cell Cycle. 2023; 22(18):2070-2087.
PMID: 37909747
PMC: 10761156.
DOI: 10.1080/15384101.2023.2275397.
Distinct t(14;19) translocation patterns in atypical chronic lymphocytic leukemia and marginal zone lymphomas.
Kuppers R
Haematologica. 2023; 109(2):376-378.
PMID: 37608774
PMC: 10828629.
DOI: 10.3324/haematol.2023.283975.
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L, Laurent C, Soma L, Ng S, Climent F, Ondrejka S
Virchows Arch. 2023; 483(3):281-298.
PMID: 37555980
PMC: 10541818.
DOI: 10.1007/s00428-023-03590-x.
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers.
DAvola A, Kluckova K, Finch A, Riches J
Onco Targets Ther. 2023; 16:371-383.
PMID: 37309471
PMC: 10257908.
DOI: 10.2147/OTT.S366627.
Whole transcriptome sequencing reveals HOXD11-AGAP3, a novel fusion transcript in the Indian acute leukemia cohort.
Desai S, Ravindran F, Panchal A, Ojha N, Jadhav S, Choudhary B
Front Genet. 2023; 14:1100587.
PMID: 37113989
PMC: 10126405.
DOI: 10.3389/fgene.2023.1100587.
Biallelic BCL6 rearrangements by dual t(3;14)(q27;q32) and t(3;22)(q27;q11) translocations in diffuse large B-cell lymphoma.
Nakamura Y, Itoh Y, Kakegawa E, Uchida Y, Ichimura T, Sasaki A
J Clin Exp Hematop. 2022; 62(4):268-272.
PMID: 36575004
PMC: 9898724.
DOI: 10.3960/jslrt.22031.
Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia.
Bagnara D, Mazzarello A, Ghiotto F, Colombo M, Cutrona G, Fais F
Int J Mol Sci. 2022; 23(22).
PMID: 36430731
PMC: 9693457.
DOI: 10.3390/ijms232214249.
Gut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation.
Rokan A, Hernandez J, Nitiyanandan R, Lin Z, Chen C, Machida T
Mol Cancer Res. 2022; 21(2):155-169.
PMID: 36287175
PMC: 9898117.
DOI: 10.1158/1541-7786.MCR-19-1209.
CRISPR/Cas9-induced structural variations expand in T lymphocytes in vivo.
Wu J, Zou Z, Liu Y, Liu X, Zhangding Z, Xu M
Nucleic Acids Res. 2022; 50(19):11128-11137.
PMID: 36243978
PMC: 9638931.
DOI: 10.1093/nar/gkac887.
Nonamer dependent RAG cleavage at CpGs can explain mechanism of chromosomal translocations associated to lymphoid cancers.
Paranjape A, Desai S, Nishana M, Roy U, Nilavar N, Mondal A
PLoS Genet. 2022; 18(10):e1010421.
PMID: 36228010
PMC: 9595545.
DOI: 10.1371/journal.pgen.1010421.
Biological and clinical significance of epigenetic alterations in B-cell lymphomas.
Ennishi D
Int J Hematol. 2022; 116(6):821-827.
PMID: 36208393
DOI: 10.1007/s12185-022-03461-2.
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
Shulman D, Whittle S, Surdez D, Bailey K, de Alava E, Yustein J
NPJ Precis Oncol. 2022; 6(1):65.
PMID: 36115869
PMC: 9482616.
DOI: 10.1038/s41698-022-00307-2.